News

FDA Advisory Panel Recommends Lamictal XR for Partial Seizures


 

FROM THE FOOD AND DRUG ADMINISTRATION

The FDA has been considering the historical controls question for several years, and its decision could affect approval of several other drugs in late-stage trials seeking similar monotherapy indications.

Used with permission from "The Pink Sheet." Internal Medicine News Digital Network and "The Pink Sheet" are published by Elsevier.

Pages

Recommended Reading

Rule Can Predict Walking Outcomes After Spinal Cord Injury
MDedge Internal Medicine
Data Link High Oral Cleft Risk to Topiramate
MDedge Internal Medicine
Spot Sign Predicts Intracerebral Hemorrhage Growth
MDedge Internal Medicine
At-Home Stroke Rehab Program as Effective as Outpatient Training
MDedge Internal Medicine
Clazosentan No Help After Aneurysmal Subarachnoid Hemorrhage
MDedge Internal Medicine
Set of Symptoms Identified to Flag Stroke Risk
MDedge Internal Medicine
Lamictal XR Study Design Problems Identified
MDedge Internal Medicine
Retrievable Stents Produce Fast Recanalization in Acute Stroke
MDedge Internal Medicine
Brain Hemorrhage Risk Higher With Late Macular Degeneration
MDedge Internal Medicine
Report Links Midlife Hypertension to Late-Life Cortical Thinning
MDedge Internal Medicine